Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Celltrion
Pharma
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
AZ's CEO is eying innovation from China as the company plots a $1.5 billion ADC plant in Singapore. The FDA rejected a combo from Hengrui and Elevar.
Angus Liu
May 24, 2024 8:31am
Celltrion signs 'The Traitors' star for bowel disease campaign
May 20, 2024 10:10am
Newly spun-off WuXi XDC locks up ADC deal with Korea's Celltrion
Jan 24, 2024 11:04am
Astellas, Otsuka, Takeda—Fierce Pharma Asia
Sep 8, 2023 9:50am
Celltrion earmarks $94.5M for new manufacturing plant: reports
Sep 5, 2023 9:30am
Carvykti, Thermo Fisher, Celltrion—Fierce Pharma Asia
May 26, 2023 9:40am
